Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
Neuroscience|July 21, 2011
α1-adrenergic receptors facilitate inhibitory neurotransmission to cardiac vagal neurons in the nucleus ambiguusC R Boychuk, R J Bateman, K E Philbin, et al.The Journal of Prevention of Alzheimer'S Disease|July 16, 2022
The Future of AD Clinical Trials with the Advent of Anti-Amyloid Therapies: An CTAD Task Force ReportJ Delrieu, R J Bateman, J Touchon, et al.Neuroscience|March 20, 2012
β adrenergic receptor modulation of neurotransmission to cardiac vagal neurons in the nucleus ambiguusR J Bateman, C R Boychuk, K E Philbin, et al.Journal of Nematology|March 11, 2009
Reducing Meloidogyne incognita Injury to Cucumber in a Tomato-Cucumber Double-Cropping SystemP D Colyer, T L Kirkpatrick, P R Vernon, et al.The Journal of Prevention of Alzheimer'S Disease|June 8, 2021
Platform Trials to Expedite Drug Development in Alzheimer's Disease: A Report from the EU/US CTAD Task ForceP S Aisen, R J Bateman, M Carrillo, et al.The Journal of Prevention of Alzheimer'S Disease|May 8, 2019
Anti-Tau Trials for Alzheimer's Disease: A Report from the EU/US/CTAD Task ForceJ Cummings, K Blennow, K Johnson, et al.The Journal of Prevention of Alzheimer'S Disease|December 18, 2020
Prospective Associations between Plasma Amyloid-Beta 42/40 and Frailty in Community-Dwelling Older AdultsW-H Lu, K V Giudici, Y Rolland, et al.The Journal of Prevention of Alzheimer'S Disease|May 8, 2019
Plasma Biomarkers of AD Emerging as Essential Tools for Drug Development: An EU/US CTAD Task Force ReportR J Bateman, K Blennow, R Doody, et al.The Journal of Prevention of Alzheimer'S Disease|November 29, 2017
Preclinical and Clinical Development of ABBV-8E12, a Humanized Anti-Tau Antibody, for Treatment of Alzheimer's Disease and Other TauopathiesT West, Y Hu, P B Verghese, et al.Journal of Neurology, Neurosurgery, and Psychiatry|June 24, 2010
Neurofilament light chain levels in ventricular cerebrospinal fluid after acute aneurysmal subarachnoid haemorrhageE R Zanier, D Refai, G J Zipfel, et al.Pageof 2